CLDN1 and Alzheimer disease: Moreover, the expression level of claudin-1 in the GI tract (114, 115) and airways (95, 116) can be downregulated by IL-4, IL-5, and IL-13 that present in patients with AD and FA, suggesting the involvement of claudin-1 in the progression of atopic inflammation to other sites.